111.51
Overview
News
Price History
Option Chain
Financials
Why A Down?
Discussions
Forecast
Stock Split
Dividend History
Agilent Technologies Inc stock is traded at $111.51, with a volume of 1.72M.
It is down -0.11% in the last 24 hours and down -11.37% over the past month.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
See More
Previous Close:
$111.63
Open:
$113.17
24h Volume:
1.72M
Relative Volume:
0.78
Market Cap:
$31.51B
Revenue:
$7.07B
Net Income/Loss:
$1.29B
P/E Ratio:
24.59
EPS:
4.5355
Net Cash Flow:
$993.00M
1W Performance:
-3.09%
1M Performance:
-11.37%
6M Performance:
-9.52%
1Y Performance:
-4.96%
Agilent Technologies Inc Stock (A) Company Profile
Name
Agilent Technologies Inc
Sector
Industry
Phone
(408) 345-8886
Address
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
A
Agilent Technologies Inc
|
111.51 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
TMO
Thermo Fisher Scientific Inc
|
464.37 | 172.51B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
187.32 | 132.46B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
573.82 | 45.69B | 4.30B | 1.06B | 1.04B | 13.08 |
|
WAT
Waters Corp
|
286.57 | 28.11B | 3.17B | 642.63M | 516.49M | 10.77 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Initiated | HSBC Securities | Buy |
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-15-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Oct-08-25 | Upgrade | UBS | Neutral → Buy |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-27-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-17-23 | Downgrade | UBS | Buy → Neutral |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| May-24-23 | Reiterated | Barclays | Equal Weight |
| May-24-23 | Reiterated | BofA Securities | Buy |
| May-24-23 | Reiterated | Citigroup | Neutral |
| May-24-23 | Reiterated | Credit Suisse | Outperform |
| May-24-23 | Reiterated | Evercore ISI | Outperform |
| May-24-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-24-23 | Reiterated | Robert W. Baird | Outperform |
| May-24-23 | Reiterated | SVB Securities | Outperform |
| May-24-23 | Reiterated | Stifel | Hold |
| May-24-23 | Reiterated | TD Cowen | Outperform |
| May-24-23 | Reiterated | Wells Fargo | Overweight |
| May-11-23 | Initiated | Barclays | Equal Weight |
| Jan-10-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jul-08-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-22 | Reiterated | BofA Securities | Buy |
| Feb-23-22 | Reiterated | Citigroup | Buy |
| Feb-23-22 | Reiterated | Cowen | Outperform |
| Feb-23-22 | Reiterated | Evercore ISI | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-23-22 | Reiterated | Wells Fargo | Overweight |
| Nov-23-21 | Reiterated | BofA Securities | Buy |
| Nov-23-21 | Reiterated | Cowen | Outperform |
| Nov-23-21 | Reiterated | Stifel | Hold |
| Mar-18-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Upgrade | UBS | Neutral → Buy |
| Nov-17-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-30-20 | Initiated | Atlantic Equities | Neutral |
| Aug-19-20 | Reiterated | BofA Securities | Neutral |
| Aug-19-20 | Reiterated | Citigroup | Neutral |
| Aug-19-20 | Reiterated | Jefferies | Buy |
| Aug-19-20 | Reiterated | Robert W. Baird | Outperform |
| Aug-19-20 | Reiterated | SVB Leerink | Outperform |
| Aug-19-20 | Reiterated | Stifel | Hold |
| Aug-19-20 | Reiterated | Wells Fargo | Overweight |
| Feb-24-20 | Downgrade | Needham | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-26-19 | Reiterated | Needham | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | UBS | Buy → Neutral |
| Jul-16-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-15-19 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Agilent Technologies Inc Stock (A) Latest News
Wellington Management Group LLP Purchases 433,342 Shares of Agilent Technologies, Inc. $A - MarketBeat
Integral Health Asset Management LLC Boosts Position in Agilent Technologies, Inc. $A - MarketBeat
Deal Dispatch: Papa John's May Go Private, Shell Buys Jiffy Lube, Meta Acquires Moltbook - Benzinga
Magnetar Financial LLC Decreases Holdings in Agilent Technologies, Inc. $A - MarketBeat
Schroder Investment Management Group Buys 75,796 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. $A Shares Purchased by Natixis Advisors LLC - MarketBeat
Preventive Control Of Sequencing Through The Insert With The Agilent 5200 Fragment Analyzer System - Bioprocess Online
Agilent Expands CDMO Role With Advanced Therapeutics As Shares Lag Targets - simplywall.st
Agilent Technologies Inc (A) Trading Down 3.59% on Mar 12 - GuruFocus
Agilent Technologies, Inc. (A) price target cut to $155 at Baird - MSN
Vestcor Inc Sells 10,204 Shares of Agilent Technologies, Inc. $A - MarketBeat
Mackenzie Financial Corp Buys 324,461 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent unifies CDMO capabilities across Canada and United States - BioSpectrum India
Legal & General Group Plc Raises Position in Agilent Technologies, Inc. $A - MarketBeat
Korea Investment CORP Has $12.95 Million Stake in Agilent Technologies, Inc. $A - MarketBeat
Agilent launches unified CDMO business combining US, Canada units - Investing.com India
Blair William & Co. IL Decreases Holdings in Agilent Technologies, Inc. $A - MarketBeat
Lab chromatographs are quietly getting an AI upgrade in the US - AD HOC NEWS
Agilent Launches Advanced Therapeutics CDMO Solution for US and Canada - Contract Pharma
Agilent’s Biocare Deal Reshapes Pathology Presence As Shares Lag Targets - simplywall.st
Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States - BioSpace
Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More - AOL.com
Agilent Technologies, Inc. $A Shares Sold by Swiss National Bank - MarketBeat
Agilent launches unified CDMO division across Canada and United States - StreetInsider
Lab Chromatographs Are Quietly Getting Smarter. Here Is Why It Matters - AD HOC NEWS
Jim Cramer on Agilent Technologies: “I Don’t Think You Need It” - Yahoo Finance
Agilent (A) Gains Positive Outlook with Analyst's 90-Day Catalys - GuruFocus
Agilent Technologies, Inc. $A Shares Sold by Russell Investments Group Ltd. - MarketBeat
Agilent Bets On Pathology Innovation With Biocare Acquisition - Yahoo Finance
Agilent Technologies announces planned retirement of principal accounting officer - Investing.com Nigeria
Agilent snaps up pathology firm Biocare Medical for $950 million - malaysiasun.com
Is Agilent Technologies Stock Underperforming the S&P 500? - Barchart
Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy - CHEManager
Van ECK Associates Corp Sells 10,815 Shares of Agilent Technologies, Inc. $A - MarketBeat
Ceredex Value Advisors LLC Makes New $24.39 Million Investment in Agilent Technologies, Inc. $A - MarketBeat
Why Agilent Technologies Just Paid $950 Million For Biocare Medical (NYSE:A) - Seeking Alpha
First Trust Advisors LP Increases Stock Position in Agilent Technologies, Inc. $A - MarketBeat
Bank of America Maintains Neutral on Agilent Technologies (A) March 2026 - Meyka
Agilent to buy Biocare Medical from Excellere and GHO Capital - pehub.com
Agilent Technologies: $950 Million Acquisition Of Pathology Diagnostics Company Biocare Medical - Pulse 2.0
Agilent Technologies to acquire Biocare Medical for $950 million - The American Bazaar
Agilent Technologies Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Agilent Technologies to Acquire Biocare Medical in $950 Million Deal - Clinical Lab Products
Why Agilent Stock Is Slipping Premarket Today - Stocktwits
Agilent to Acquire Biocare Medical in $950 Million All-Cash Deal - TradingView
Sullivan & Cromwell Advises Agilent On $950M Biocare Buy - Law360
Agilent to buy Biocare Medical for $950M - Healthcare Dive
Agilent Technologies to acquire Biocare Medical in $950m deal - Medical Device Network
Agilent TechnologiesConsidering Adding Here, As It Adds To Its Portfolio (NYSE:A) - Seeking Alpha
Agilent buys Biocare for $950M - BioWorld MedTech
BofA reiterates Agilent stock rating on Biocare acquisition - Investing.com
Agilent Technologies Inc Stock (A) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):